
Khatol S. Shahnan Shah
Examiner (ID: 17930, Phone: (571)272-0863 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 691 |
| Issued Applications | 342 |
| Pending Applications | 101 |
| Abandoned Applications | 266 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9875543
[patent_doc_number] => 08962812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Methods of extracting chemical compounds from organisms with resistant cell walls'
[patent_app_type] => utility
[patent_app_number] => 13/655925
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2765
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655925
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/655925 | Methods of extracting chemical compounds from organisms with resistant cell walls | Oct 18, 2012 | Issued |
Array
(
[id] => 9777396
[patent_doc_number] => 08852596
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-10-07
[patent_title] => 'Detection of Giardia lamblia trophozoites and cysts and protection against G. lamblia infection'
[patent_app_type] => utility
[patent_app_number] => 13/651830
[patent_app_country] => US
[patent_app_date] => 2012-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8586
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651830
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/651830 | Detection of Giardia lamblia trophozoites and cysts and protection against G. lamblia infection | Oct 14, 2012 | Issued |
Array
(
[id] => 9771794
[patent_doc_number] => 20140295457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN'
[patent_app_type] => utility
[patent_app_number] => 14/351255
[patent_app_country] => US
[patent_app_date] => 2012-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28843
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351255
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351255 | Gene cluster for biosynthesis of griselimycin and methylgriselimycin | Oct 10, 2012 | Issued |
Array
(
[id] => 9670462
[patent_doc_number] => 20140234325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'ADJUVANT THERAPY FOR STAPHYLOCOCCAL INFECTION WITH ENTEROTOXIN SPECIFIC MABS'
[patent_app_type] => utility
[patent_app_number] => 14/346981
[patent_app_country] => US
[patent_app_date] => 2012-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23906
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346981 | ADJUVANT THERAPY FOR STAPHYLOCOCCAL INFECTION WITH ENTEROTOXIN SPECIFIC MABS | Sep 25, 2012 | Abandoned |
Array
(
[id] => 12008650
[patent_doc_number] => 09801948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Antimicrobial compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/343809
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 27246
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343809
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343809 | Antimicrobial compositions and methods of use thereof | Sep 20, 2012 | Issued |
Array
(
[id] => 15756203
[patent_doc_number] => 10620205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => NMR methods for endotoxin analysis
[patent_app_type] => utility
[patent_app_number] => 14/345803
[patent_app_country] => US
[patent_app_date] => 2012-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10470
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345803
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/345803 | NMR methods for endotoxin analysis | Sep 19, 2012 | Issued |
Array
(
[id] => 11928662
[patent_doc_number] => 09795640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance'
[patent_app_type] => utility
[patent_app_number] => 14/345906
[patent_app_country] => US
[patent_app_date] => 2012-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 24
[patent_no_of_words] => 12426
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345906
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/345906 | Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance | Sep 18, 2012 | Issued |
Array
(
[id] => 10219460
[patent_doc_number] => 20150104454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'ANTI-C.DIFFICILE TOXIN ANTIBODIES AND ASSOCIATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/344749
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2442
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344749
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344749 | Anti-C. difficile toxin antibodies and associated methods | Sep 12, 2012 | Issued |
Array
(
[id] => 10933345
[patent_doc_number] => 20140336366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'BIOCONJUGATE VACCINES MADE IN PROKARYOTIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/342958
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 15471
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342958
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342958 | BIOCONJUGATE VACCINES MADE IN PROKARYOTIC CELLS | Sep 5, 2012 | Abandoned |
Array
(
[id] => 10932519
[patent_doc_number] => 20140335540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/238451
[patent_app_country] => US
[patent_app_date] => 2012-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7797
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238451
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238451 | METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS | Aug 12, 2012 | Abandoned |
Array
(
[id] => 10932519
[patent_doc_number] => 20140335540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/238451
[patent_app_country] => US
[patent_app_date] => 2012-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7797
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238451
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238451 | METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS | Aug 12, 2012 | Abandoned |
Array
(
[id] => 11304803
[patent_doc_number] => 09512189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Optimized antigens of pneumocystis and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/237133
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 15194
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237133
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237133 | Optimized antigens of pneumocystis and use thereof | Aug 5, 2012 | Issued |
Array
(
[id] => 9785263
[patent_doc_number] => 20140302084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'IMMUNOGENIC PROTEIN CONJUGATES AND METHOD FOR MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/237320
[patent_app_country] => US
[patent_app_date] => 2012-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11894
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237320
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237320 | IMMUNOGENIC PROTEIN CONJUGATES AND METHOD FOR MAKING AND USING THE SAME | Aug 4, 2012 | Abandoned |
Array
(
[id] => 9560600
[patent_doc_number] => 20140178313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR ORAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/236849
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15545
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236849
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236849 | Prophylactic or therapeutic agent for oral diseases | Aug 2, 2012 | Issued |
Array
(
[id] => 11217802
[patent_doc_number] => 09446122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens'
[patent_app_type] => utility
[patent_app_number] => 14/234983
[patent_app_country] => US
[patent_app_date] => 2012-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 7328
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234983
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234983 | Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens | Jul 27, 2012 | Issued |
Array
(
[id] => 9756258
[patent_doc_number] => 20140286960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'STAPHLOCOCCUS AUREUS ALPHA-HEMOLYSIN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/235315
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13001
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/235315 | STAPHLOCOCCUS AUREUS ALPHA-HEMOLYSIN ANTIBODIES | Jul 26, 2012 | Abandoned |
Array
(
[id] => 9735936
[patent_doc_number] => 20140271649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING STAPHYLOCOCCUS AGGLUTINATION IN BLOOD'
[patent_app_type] => utility
[patent_app_number] => 14/233109
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22858
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233109
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233109 | METHODS AND COMPOSITIONS FOR INHIBITING STAPHYLOCOCCUS AGGLUTINATION IN BLOOD | Jul 12, 2012 | Abandoned |
Array
(
[id] => 8515850
[patent_doc_number] => 20120315258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'BACILLUS STRAINS AND METHODS FOR REDUCING E. COLI DISEASE AND ENHANCING PERFORMANCE'
[patent_app_type] => utility
[patent_app_number] => 13/494468
[patent_app_country] => US
[patent_app_date] => 2012-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17641
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494468
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/494468 | Bacillus strains and methods for reducing E. coli disease and enhancing performance | Jun 11, 2012 | Issued |
Array
(
[id] => 9597196
[patent_doc_number] => 20140193876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN'
[patent_app_type] => utility
[patent_app_number] => 14/125695
[patent_app_country] => US
[patent_app_date] => 2012-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14803
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125695
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125695 | METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN | Jun 7, 2012 | Abandoned |
Array
(
[id] => 8509188
[patent_doc_number] => 20120308596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'NOVEL STREPTOCOCCUS ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 13/491088
[patent_app_country] => US
[patent_app_date] => 2012-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 16032
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/491088 | NOVEL STREPTOCOCCUS ANTIGENS | Jun 6, 2012 | Abandoned |